A strong trend was demonstrated where NDRG1 was linked to tumor aggressiveness features being most amplified in the basal-like subtype (36%), followed by the HER2+ (25%) and luminal A (2.8%) subtypes (19). Here, NDRG1 is linked to neoplasm.